BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• BioMidwest

  ProSensa Holding N.V. Publishes A Sensitive, Reproducible And Objective Methodology For Dystrophin Analysis In Patients With Duchenne Muscular Dystrophy

  September 24, 2014

   · 

  2 min read
• Business

  Cortex Pharmaceuticals, Inc. Announces Phase 1 Funding By The National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) Under The Small Business Innovation Research Funding Award Program

  September 24, 2014

   · 

  5 min read
• USDA Acquires Protea Biosciences, Inc.'s LAESI® Technology Platform

  September 24, 2014

   · 

  3 min read
• Biotech Bay

  Ultragenyx Pharmaceuticals To Present At The Leerink Partners Rare Disease Roundtable

  September 24, 2014

   · 

  1 min read
• Pharm Country

  Dominion Diagnostics Release: Improvement Of Abstinence In Chemical Dependence Treatment Programs With Comprehensive Analysis Of Reported Drugs (CARD)®

  September 24, 2014

   · 

  4 min read
• BoneSupport Release: Twelve-Month Follow-Up Of CERAMENT™ With Gentamicin Confirms Significant And Sustained Eradication Of Chronic Infection And Demonstrated Formation Of New Bone

  September 24, 2014

   · 

  3 min read
• Business

  IMRIS Announces Waiver And Amendment Agreement And Repricing Of Warrants

  September 24, 2014

   · 

  3 min read
• Biotech Beach

  Regulus Therapeutics, Inc. Announces Notice Of Allowance From U.S. Patent Office Related To Microrna-103/107 Program In Metabolic Disorders

  September 24, 2014

   · 

  7 min read
• Pharm Country

  ePharmaSolutions Joins the WIRB-Copernicus Group

  September 24, 2014

   · 

  3 min read
• Policy

  World Health Organization Issues Prequalification Of Becton, Dickinson and Company FACSPresto™ Near-Patient CD4 Counter System For HIV/AIDS Monitoring

  September 24, 2014

   · 

  4 min read